Why high U.S. drug prices matter to Canada

In the mid-1970s the average monthly cost of a cancer drug in the United States was about $100. By 1995 that cost had crept up to about $1,800 per month and today it is over $10,000. Similarly, while drugs for multiple sclerosis introduced in the mid-1990s cost about $8,000 per…
Read more

USMCA: Red tape for public safety regulators

The CCPA continues to carefully read through the nearly 2,000-page USMCA text. This blog, the third in a series on how the agreement differs from NAFTA, examines the agreement’s chapter on Good Regulatory Practices, a relatively new addition to so-called next generation trade deals. Stay tuned to this space for continued analysis…
Read more

Ce n’est pas ce qu’on ajoute aux accords commerciaux, mais ce qu’on y enlève qui garantit leur caractère progressiste

Le gouvernement fédéral veut nous faire croire que l’élection de 2015 a marqué le début d’une ère du « commerce progressiste » au Canada. En guise de preuve, les ministres libéraux brandiront l’ajout d’un chapitre sur l’égalité des genres dans la nouvelle mouture de l’Accord de libre-échange Canada-Chili, ou encore la proposition…
Read more